Dian-Ping Yi

From mutation detection to treatment decisions: CRISPR-enabled diagnostics for drug-resistant tuberculosis

Effective management of drug-resistant tuberculosis requires molecular assays that not only detect Mycobacterium tuberculosis but also identify resistance-associated variants, support drug-level interpretation, and indicate when broader confirmatory testing is needed. This narrative review applies a mutation-to-drug-to...